Mark Butler's decision to 'respectfully' write to the PBAC to ask that it reconsider its previous advice on the GSK therapies was an unnecessary but subtle and entirely legitimate exercise of this ministerial power over PBS decision-making.
The minister did not need the committee's advice to reverse these changes
May 15, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News -
Budget update includes impact of listings, but generally not much else
December 16, 2025 - - Latest News -
The UK reconfirms the direct impact of the transatlantic shift in medicine pricing
December 16, 2025 - - Latest News -
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News
